✦ LIBER ✦

SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma

✍ Scribed by Papp, Gergő; Changchien, Yi-Che; Péterfia, Bálint; Pecsenka, Loránd; Krausz, Thomas; Stricker, Thomas P; Khoor, Andras; Donner, Ludvik; Sápi, Zoltán

Book ID: 120015490
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 756 KB
Volume: 26
Category: Article
ISSN: 0893-3952
DOI: 10.1038/modpathol.2012.190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SMARCB1 expression in epithelioid sarcom

SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels

✍ Papp, Gergő; Krausz, Thomas; Stricker, Thomas P.; Szendrői, Miklós; Sápi, Zoltán 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

The loss of NKX3.1 expression in testicu

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation

✍ Guro E Lind; Rolf I Skotheim; Mario F Fraga; Vera M Abeler; Rui Henrique; Fahri 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 534 KB

The extracellular matrix protein ITIH5 i

The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation

✍ Veeck, J; Chorovicer, M; Naami, A; Breuer, E; Zafrakas, M; Bektas, N; Dürst, M; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 526 KB

HBe antigen loss during lamivudine thera

HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B

✍ Fumitaka Suzuki; Akihito Tsubota; Yasuji Arase; Yoshiyuki Suzuki; Norio Akuta; T 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract HBe antigen (HBeAg) loss or seroconversion can occur during lamivudine therapy. The purpose of this study was to analyze nucleotide sequences in precore and core promoter regions, and examine the influence of mutations in these regions on the disappearance of HBeAg during lamivudine the